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Effects of extended-release eprinomectin on productivity measures in cow–calf 
systems and subsequent feedlot performance and carcass characteristics of 
calves 
Abstract 
The objective of this study was to estimate the impact of a single injection of extended-release 
eprinomectin on economically relevant production variables in beef cows and calves as well as 
subsequent feedlot health, performance, and carcass traits of calves compared with a traditional, short 
duration anthelmintic. Animals from 13 cooperator herds across seven states were stratified within herd 
and assigned to one of two treatments; injectable doramectin (DOR; Dectomax; n = 828) or injectable 
eprinomection (EPR; Longrange; n = 832). Fecal samples were randomly collected from a subset of cows 
at both treatment and the end of grazing to evaluate fecal egg count (FEC). Continuous and categorical 
data were analyzed using the MIXED and GLIMMIX procedures of SAS, respectively. Cow treatment body 
weight (BW) and final BW were not different (P ≥ 0.40) between treatments. There were no differences (P 
≥ 0.12) between treatments in cow ADG, change in BW, or body condition scores during the grazing 
season. While FEC at treatment did not differ (P = 0.18), cows treated with EPR had lower final FEC at the 
end of the grazing season (P = 0.02) and a greater reduction of FEC over the grazing season (P = 0.01). 
Calf treatment BW, weaning BW, and ADG did not differ between treatments (P ≥ 0.34). Incidence of 
pinkeye tended to be less (P = 0.06) for cows treated with EPR but was not different for calves (P = 0.43). 
Conception to AI, overall pregnancy rates, and calving interval were not different between treatments (P ≥ 
0.45). A subset of calves from each herd was sent to Tri-County Steer Carcass Futurity (TCSCF) feedlot 
for the finishing phase. Calf BW did not differ at initiation of feeding (P = 0.20). While EPR calves tended 
to be heavier at reimplantation (P = 0.07), final BW and overall ADG were not different between treatments 
(P ≥ 0.13). Health records indicated lower morbidity for EPR calves (P = 0.05). Carcass performance 
including HCW, dressing percent, backfat, KPH, REA, YG, were not different between treatment groups (P 
≥ 0.12). However, EPR calves had a greater marbling score, greater average quality grade (P < 0.01), and 
higher proportion of calves that graded average choice or greater (P = 0.03). Results of this study indicate 
no difference in cow or preweaning calf performance, however, carcass quality in the feedlot phase was 
improved. Thus, economic analysis indicates opportunities for return on investment if animals treated 
with EPR have improved health status and/or carcass quality during the feeding phase. 
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ABSTRACT: The objective of this study was to 
estimate the impact of a single injection of extend-
ed-release eprinomectin on economically relevant 
production variables in beef cows and calves as well 
as subsequent feedlot health, performance, and car-
cass traits of calves compared with a traditional, 
short duration anthelmintic. Animals from 13 
cooperator herds across seven states were stratified 
within herd and assigned to one of two treatments; 
injectable doramectin (DOR; Dectomax; n = 828) 
or injectable eprinomection (EPR; Longrange; 
n  =  832). Fecal samples were randomly collected 
from a subset of cows at both treatment and the 
end of grazing to evaluate fecal egg count (FEC). 
Continuous and categorical data were analyzed 
using the MIXED and GLIMMIX procedures 
of SAS, respectively. Cow treatment body weight 
(BW) and final BW were not different (P ≥ 0.40) 
between treatments. There were no differences (P 
≥ 0.12) between treatments in cow ADG, change 
in BW, or body condition scores during the graz-
ing season. While FEC at treatment did not differ 
(P = 0.18), cows treated with EPR had lower final 
FEC at the end of the grazing season (P = 0.02) and 
a greater reduction of FEC over the grazing season 
(P = 0.01). Calf treatment BW, weaning BW, and 
ADG did not differ between treatments (P ≥ 0.34). 
Incidence of pinkeye tended to be less (P = 0.06) 
for cows treated with EPR but was not different 
for calves (P  =  0.43). Conception to AI, overall 
pregnancy rates, and calving interval were not dif-
ferent between treatments (P ≥ 0.45). A  subset of 
calves from each herd was sent to Tri-County Steer 
Carcass Futurity (TCSCF) feedlot for the finishing 
phase. Calf BW did not differ at initiation of feeding 
(P = 0.20). While EPR calves tended to be heavier 
at reimplantation (P = 0.07), final BW and overall 
ADG were not different between treatments (P ≥ 
0.13). Health records indicated lower morbidity for 
EPR calves (P = 0.05). Carcass performance includ-
ing HCW, dressing percent, backfat, KPH, REA, 
YG, were not different between treatment groups 
(P ≥ 0.12). However, EPR calves had a greater mar-
bling score, greater average quality grade (P < 0.01), 
and higher proportion of calves that graded average 
choice or greater (P = 0.03). Results of this study 
indicate no difference in cow or preweaning calf  
performance, however, carcass quality in the feedlot 
phase was improved. Thus, economic analysis indi-
cates opportunities for return on investment if ani-
mals treated with EPR have improved health status 
and/or carcass quality during the feeding phase.
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INTRODUCTION
It has been well documented that gastrointes-
tinal parasites can be detrimental to cattle health 
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and performance. Production parameters impacted 
by parasitic infection include weight gain, repro-
ductive efficiency, health, feedlot performance, and 
carcass quality (Hawkins, 1993). Since the 1960’s, 
anthelmintic treatment has been a staple in ruminant 
production systems to mitigate production losses 
caused by helminth infection. In cow–calf produc-
tion, anthelmintic treatment has been shown to 
improve cow BW and body condition scores (BCS), 
increase overall breeding season pregnancy rates, 
and improve calf performance (Stuedemann et al., 
1989; Wohlgemuth et  al., 1990; Stromberg et  al., 
1997; Hersom et  al., 2011). The effects of anthel-
mintic treatment during the feeding phase have been 
shown to improve ADG, feed to gain (F:G), daily 
dry matter intake, and final BW (Smith et al., 2000). 
Furthermore, studies have linked calfhood deworm-
ing treatment to improved lifetime performance 
including growth, reproduction, and health (Mejia 
et al., 1999; Stacey et al., 1999; Clark et al., 2015).
In 2012, Merial, Inc. released an extended-re-
lease version of the anthelmintic drug, eprinomec-
tin. This product label claims 100–150 d of parasite 
protection with one injection. Evaluation of concen-
tration of eprinomectin shows effective plasma con-
centrations up to 150 d postadministration (Solls 
et al., 2013). Studies with stocker cattle have proven 
that extended-release eprinomectin effectively 
reduces worm burdens and improves weight gains 
in this class of cattle (Rehbein et al., 2013a, 2013b, 
Clark et al., 2014). However, to date, little research 
has been published regarding the effects of extend-
ed-release eprinomectin on cow–calf performance. 
Therefore, the objective of this study was to assess 
economically relevant performance parameters in 
cow herds following administration of extended-re-
lease eprinomectin at the start of the grazing sea-
son and to assess subsequent feedlot performance 
of progeny. We hypothesized that treatment of 
cows and calves with extended-release eprinomectin 
would improve cow performance and reproductive 
success and positively impact progeny performance 
compared to a short duration anthelmintic.
MATERIALS AND METHODS
All procedures and protocols were approved 
by the Iowa State University Institutional Animal 
Care and Use Committee (3-16-8209-B).
Survey
Because one of the study goals was to fol-
low progeny through the feedlot phase to assess 
health and performance, Tri-County Steer Carcass 
Futurity (TCSCF) cooperators were identified as 
cooperators for this study because of the retained 
ownership platform (Reinhardt et al., 2009).
In May 2015, a Qualtrics survey (Qualtrics, 
Provo, UT) was administered by TCSCF and Iowa 
State University to screen potential cooperator 
herds. Survey questions were aimed at identifying 
management styles, record keeping, and herd health 
protocols. Questions inquired about current para-
site control programs including if  a parasite con-
trol program was in place, what type of dewormer 
was used (i.e., pour-on or injectable), which classes 
of cattle were commonly dewormed in the opera-
tion (i.e., cows, calves, or both), and postweaning 
parasite management of calves. Other questions 
identified common production practices such as if  
and when body weights were typically recorded, if  
and when BCS were recorded, when calving sea-
son typically began and ended, if  calving data were 
recorded, and if  pregnancy checks were conducted.
In order to qualify for participation in the study, 
producers must have had a parasite control program 
in place as part of a herd health protocol and be 
able to provide accurate visual ID records for both 
cows and calves. Birth records, including birth date, 
sex, and birth weight, for both the year of initial 
treatment (2016) and the subsequent calving season 
(2017) must have been available. Producers must 
have had the ability to collect timely and accur-
ate measurements including cow and calf  BW and 
cow BCS at the time of treatment and at weaning. 
Necessary reproduction data included pregnancy 
checks for both spring- and fall-calving herds with 
fetal aging if  possible, AI dates (if  applicable) as 
well as length of bull exposure. Producers that 
met minimum requirements were then selected for 
participation in the study. It is important to note 
that producers participating in this study were not 
required to have any history of parasitic infection 
within their herd nor were they required to identify 
the level of parasitic infection prior to the initiation 
of the study.
Experimental Design
Twelve cooperator herds located in seven states 
(Iowa, Missouri, Indiana, Kentucky, Tennessee, 
Ohio, and Georgia) participated in the study. The 
total number of animals enrolled in the trial was 
1,768 cow–calf  pairs and included both spring- and 
fall-calving herds. Animals were stratified within 
herd by cow age, calf  birth date, calf  birth BW, and 
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injectable doramectin (DOR; Dectomax, Zoetis, 
Animal Health, Parsippany, NJ; n = 879) or inject-
able eprinomection (EPR; LongRange, Merial, 
Duluth, GA; n  =  889) at a rate of 1  mL/50  kg. 
Treatments were administered in the spring of 2016 
during pasture turnout (Table 1). Average pasture 
turn-out date for participating herds was 16 May 
2016. On average, treatments were administered on 
9 May 2016 with a treatment range of March 23rd 
to June 15th. Individual and overall herd charac-
teristics at the time of treatment are presented in 
Table 1. Overall, at treatment administration, cows 
averaged 5  ±  3.0 yr of age, weighed 568  ±  92  kg 
with an average BCS of 5.4 ± 0.9, and were 69 ± 33 
d postpartum (DPP). One hundred and eight pairs 
(n = 51 DOR; n = 57 EPR) were removed from the 
trial due to nontreatment-related issues including 
mortality, morbidity, or culling during the grazing 
season.
The study consisted of two different treatment 
tiers. In tier one, only cows were treated. Following 
treatment, EPR cows were managed on similar but 
separate pastures from DOR cows and treatments 
were not comingled at any time between treatment 
and weaning. Moreover, cows were not grazed in 
pastures where the opposite treatment had grazed 
previously during the grazing season. In tier two, 
EPR cows and DOR cows were comingled from 
the start of the trial. At approximately 90 d of age, 
per label instructions, calves were treated with the 
identical product as their dams. Both dams and 
calves only received a single dose of their respective 
anthelmentic throughout the duration trial. The 
two-tier design implemented in this study allowed 
for unique evaluation of both parasite burden and 
performance response. In order to maintain sep-
arate parasite burdens relative to treatment, tier 
one was implemented. This design prevents EPR 
cows from potentially diminishing parasite loads 
that DOR may otherwise have been exposed to. 
However, because reproductive variables were of 
interest in this study, tier two was implemented 
in order to evenly apply variables, such as natural 
service sires, between treatment groups. Although 
forage data including quality and type were not 
collected, tier two allowed for mitigation of for-
age type and quality variables that often confound 
results in replicated grazing studies. It is impor-
tant to note that previous studies have successfully 
detected performance and parasite load differences 
between anthelmintic treatments that were comin-
gled in a grazing environment (Clark et al., 2013; 
Watson, 2016).
Production Measures
Performance. Cow body weights (BW) and 
body condition scores (BCS; 1–9; Wagner et  al., 
1988) were taken at the time of treatment and again 
at the end of the trial. The end of the trial was dif-
ferentially determined based on calving season. For 
spring-calving cows, end of trial was considered 
Table 1. Age, calving date, birth weight, treatment date, days postpartum, BW, and BCS of cows from 
cooperating herds enrolled in the study
Herd1 n
Mean age, years 
(range)
Julian calving 














1 75 5.4 (2–13) 56 (16–97) 36 (25–49) 160 (160–161) 104 (63–144) 576 (431–750) 5.5 (4.0–9.0)
2 51 4.8 (2–11) 58 (23–101) --- 124 (121–128) 69 (27–105) 582 (452–716) 6.0 (4.0–8.0)
3 40 5.1 (3–10) 90 (12–201) --- 91 (---) 0.6 (−110–79) 591 (448–740) 6.2 (4.0–8.0
4 164 4.9 (2–13) 23 (−2–57) 33 (21–49) 89 (81–104) 67 (26–93) 541 (350–769) 5.8 (4.0–8.0)
5 194 4.8 (2–12) 18 (−18–109) --- 139 (122–153) 120 (44–166) 621 (376–858) 4.3 (3.0–6.0)
6 67 4.2 (2.0–11) 72 (125–136) --- 128 (125–136) 56 (19–91) 658 (372–803) 4.3 (3.0–6.0)
7 402 5.7 (2–14) 127 (16–290) 37 (18–52) 150 (116–166) 69 (31–143) 522 (306–796) 5.7 (3.3–8.0)
8 129 5.2 (2–15) 142 (19–291) 39 (23–56) 140 (126–147) 60 (14–128) 621 (495–782) 5.4 (4.0–7.3)
9 188 6.2 (2–14) 109 (51–268) 37 (27–45) 131 (130–133) 49 (7–79) 602 (413–759) 5.4 (4.3–7.3)
10 118 4.3 (2–16) 85 (45–148) 34 (20–49) 127 (126–132) 43 (−22–87) 566 (395–744) 5.5 (4.0–7.5)
11 90 3.9 (2–10) 81 (57–112) 33 (21–43) 126 (---) 45 (14–69) 537 (372–779) 5.7 (4.0–8.0)
12 248 5.8 (2–15) 110 (79–167) 35 (16–51) --- --- --- ---
Overall 1,766 5.3 (2–16) 89 (−19–291) 36 (16–56) 133 (81–166) 70 (−110–166) 568 (306–858) 5.4 (2.0–9.0)
1Herds were located in seven different states.
2Julian date of treatment within a herd.
3Days postpartum at anthelmintic administration.
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as time of weaning. For fall-calving herds, end of 
the trial was considered when pairs were removed 
from pasture. Calves that were in tier two of the 
trial were weighed at the time of treatment (n = 543 
DOR; n=543). All calves in the study were weighed 
at the time of weaning (n  =  828 DOR; n  =  832 
EPR). Birth weights of fall calves (n  =  79 DOR; 
73 EPR) were evaluated as a response variable to 
anthelmintic treatment. It is well established that 
nutritional status during gestation plays a crucial 
role in fetal development and postnatal progeny 
performance. Undernutrition, such as often seen 
during a parasitic infection, can be detrimental to 
development and lifetime performance of an ani-
mal by decreasing birth weight, impacting devel-
opment during gestation, and ultimately altering 
postnatal metabolism and performance (Funston 
et  al., 2009; Canton and Hess, 2010). Forty-four 
calves were removed from final analysis due to 
administration of the incorrect anthelmintic treat-
ment (n = 21 DOR; n = 23 EPR).
Fecal samples. Fecal samples were taken from a 
subset of five herds. Approximately 15 cows per 
treatment were randomly selected at each location 
and were sampled at the start (n = 75 DOR; n = 69 
EPR) and end (n = 70 DOR; n = 65 EPR) of the 
trial to measure initial and final fecal egg counts 
(FEC). Samples collected included both spring- 
and fall-calving herds as well as herds from both 
experimental tiers. All fecal samples were shipped 
to Texas A&M Diagnostic Lab for analysis of FEC 
as well as coproculture if  warranted.
Health outcomes. Available herd health records 
were used to analyze incidence of pinkeye over the 
course of the grazing season. Health records were 
submitted from two herds and both indicated treat-
ment records for pinkeye for cows (n = 323 DOR; 
n = 325 EPR) and calves (n = 312 DOR; n = 308 
EPR). In July, fly counts were conducted on a subset 
of five herds to evaluate fly burden. Herds included 
in the analysis consisted of both experimental tiers 
as well as both spring- and fall-calving herds. Live 
fly counts were evaluated in the pastures (n = 151 
DOR; 150 EPR) in mid-July. Within a pasture, 
animals were selected at random and fly burdens 
were estimated from a single side of the animal and 
included face, shoulders, back, and legs. Flies were 
counted individually until the number exceeded 25, 
and then counted in groups of 5 (Steelman et al., 
1997). Estimations from a single side were then dou-
bled to obtain a full body estimate of fly burden. At 
the time of live evaluation, pictures (n = 133 DOR; 
n = 134 EPR) were taken of the side used in the live 
analysis for fly count confirmation.
Reproduction end  points. For all herds, overall 
breeding season pregnancy rates were collected for 
both spring and fall herds (n = 828 DOR; n = 832 
EPR). Of participating herds, six producers imple-
mented AI protocol. Where applicable, conception 
rates to AI were analyzed (n = 334 DOR; n = 327 
EPR). Calving distribution for the 2017 calving 
season was evaluated as well as calving interval 
between 2016 and 2017 calving for all spring-calv-
ing herds (n = 610 DOR; n = 611 EPR).
Feedlot and carcass  data. After weaning, calves 
were managed at individual cooperating locations 
per the standard operating procedure of each farm. 
Although postweaning management of calves was 
not controlled as part of the study, requirements 
established by TCSCF for calves entering the pro-
gram ensured comparable health management 
between producers. To qualify for TCSCF, calves 
must be weaned for a minimum of 30 d, be castrated 
and dehorned, and treated for internal and external 
parasites. Calves must also have been administered 
two doses of the following vaccinations: infectious 
Bovine rhinotracheitis (IBR), Bovine viral diar-
rhea virus (two types; BVD), parainfluenza (PI3), 
Bovine respiratory syncytial virus (BRSV), and sev-
en-way blackleg.
A subset of calves from each herd at the discre-
tion of the cooperator was then sent to a TCSCF 
feedlot for the finishing phase. Calves arrived at 
the feedlot between 16 October and 22 December 
2016 (n = 238 DOR; n = 259 EPR). Upon arrival, 
calves were vaccinated with a five-way and sev-
en-way. Calves were also administered a dewormer, 
implanted, tagged, and weighed. Cattle were tran-
sitioned to an 80% concentrate diet over a 28-d 
period. While at TCSCF, feedlot performance 
and health were monitored. Finished cattle were 
harvested between 21 March and 6 July 2017. 
Following slaughter, carcass data were collected. 
Thus, feedlot performance, morbidity, and carcass 
parameters were analyzed.
Economic Analysis
Extended-release eprinomectin (EPR) is mar-
keted as offering novel performance response and 
has a label-claim for lengthened protection. However, 
the cost of this product is in an added out-of-pocket 
expense to producers compared to conventional 
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analysis evaluating production responses to anthel-
mintic treatment and thus, economic impact on pro-
ducers, was conducted. The goal of this analysis was 
to evaluate the initial cost of treatment and the dif-
ferential performance needed for producers to make 
up the increased cost of EPR compared to a con-
ventional parasite control product like DOR.
The economic model used for the cow–calf  
enterprise analysis was a partial budget (Texas 
Cooperative Extension, 2002). For this analysis, a 
treatment herd was standardized to 100 cow–calf  
pairs. Margin over cost was set at 0% to determine 
breakeven prices and labor was considered equal 
between the two treatment groups. A  standard 
weaned calf  percentage of 90% was used for both 
treatments. An average weaning weight of 238 kg 
was used for both the treatments. In addition to the 
baseline analysis, alternative scenarios were ana-
lyzed by increasing or decreasing calf  prices by 20% 
while holding all other variables constant.
An enterprise budget was used for the analysis 
of the feedlot data (Ag Decision Maker, 2017). 
Budgets for each treatment group were created 
using actual records and prices reported by TCSCF.
Statistical Analysis
Cow–calf  analysis. Performance data and calv-
ing interval were analyzed using the MIXED 
procedure of SAS 9.4. Conception to AI, overall 
breeding season pregnancy rates, calving distribu-
tion, and health outcomes were analyzed using the 
GLIMMIX procedure of SAS 9.4. Cow, or calf  
when appropriate, was the experimental unit for the 
analysis. The model included fixed effects of treat-
ment, season, tier, calf  sex when appropriate, and 
included the random effect of pasture nested within 
location to account for variation within and across 
herds relative to management and weather.
Feedlot performance and carcass quality analy-
sis. Feedlot and carcass performance were ana-
lyzed using the MIXED procedure of SAS 9.4. 
Quality grade distribution and morbidity were 
analyzed using the GLIMMIX procedure of SAS 
9.4. Calf  was the experimental unit for the analysis. 
The model included fixed effect of treatment, tier, 
season, a covariate of calf  sex, and included the 
random effect of pasture nested within producer to 
account for variation in management.
Tier and season were tested as main effects and 
for interaction and removed if  no interaction was 
detected. Significance was declared at P ≤ 0.05 and 
tendencies 0.05 ˂ P ≤ 0.10.
RESULTS AND DISCUSSION
The objective of this study was to measure a 
multitude of standard, economically relevant pro-
duction variables of beef cows and calves as well 
as subsequent feedlot health, performance, and 
carcass traits of those calves from herds that were 
administered extended-release eprinomectin com-
pared to dectomax 1% injectable at the labeled 
dose rate.
Cow Performance
Cow performance data are presented in Table 2. 
Initial and final BW did not differ due to treatment 
(P ≥ 0.32). In addition, change in BW over the 
course of the trial was not different and there was 
no difference in change in BW as a percent of initial 
BW which correlated into no differences in ADG 
(P ≥ 0.12). Subsequently, there were no differences 
in either initial or final BCS (P ≥ 0.23) as a result 
of treatment. While previous literature has found 
weight differences (Ciordia et al. 1982; Stuedemann 
et al. 1989), comparisons have predominately been 
made between dewormed groups and nontreated 
controls. However, the present study compares dif-
ferences between two groups treated with anthel-
mintics that differ in duration of efficacy. Results 
from a similar study (Backes et  al., 2016) have 
reached comparable conclusions showing no over-
all weight difference between groups treated with 
a conventional short duration oral oxfendazole or 
extended-release eprinomectin. However, Myers 
(1988) has suggested that increased performance in 
the form of improved milk production or reproduc-
tive success following anthelmintic treatment may 
confound cow weights so that weights may not be 
a meaningful production parameter when studying 
parasite control in cow–calf  production.
Health Outcomes
Previous studies have indicated some level of fly 
control associated with treatment with extended-re-
lease eprinomectin in grazing environments (Vesco 
et al., 2015; Trehal et al., 2017). Anecdotal evidence 
has found reduced fly burdens with lower incidence 
of pinkeye in grazing cattle that were treated with 
extended-release eprinomectin. While extended-re-
lease eprinomectin is not labeled for fly control, 
one of the objectives of the current study was to 
evaluate claims of reduced fly burden and inci-
dence of pinkeye. An evaluation of fly burden in 
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EPR and DOR treated cows (P ≥ 0.62; Table  3). 
These results are similar to those reported by 
Watson (2016), where there were no differences in 
fly counts between control, combination treatment 
of oxfendazole and moxidectin, or extended-re-
lease eprinomectin-treated calves comingled during 
a 100-d stocker period. Interestingly, EPR cows 
in the current study tended to have a lower inci-
dence of pinkeye as reported by treatment records 
(DOR = 8.4%; EPR = 4.6%; P = 0.06), however, 
this reduction is not explained by differences in fly 
burden. When evaluating incidence of pinkeye in 
calves, there was no difference in pinkeye treatment 
between treatment groups (P = 0.43).
There has been speculation that the fly con-
trol associated with extended-release eprinomectin 
is correlated with the reduction in pinkeye within 
treated herds. Fly control following treatment 
with extended-release eprinomectin is believed 
to be a result of residue in manure pats that dis-
rupt egg and larval development of fly species that 
use the manure to procreate, in a manner similar 
to an insect-growth regulator (IGR). While treat-
ment with extended-release eprinomectin has been 
shown to reduce horn fly burdens in grazing stocker 
cattle (Trehal et al., 2017), there is no data on its 
effectiveness on face flies, the main transmitters of 
pinkeye within a grazing herd. Furthermore, face 
flies can travel long distances and spend minimal 
time on an animal, making control of these pests 
difficult with products such as IGR (Antonelli and 
Ramsay, 2014). Therefore, it is hard to identify a 
causal relationship between fly control and pinkeye 
with this product. More research is necessary to 
verify and determine the relationship, if  one exists, 
between these two variables.
Reproduction
Marked improvement in reproductive success 
of both mature cow herds and developing heifers 
have been noted following administration of anthel-
mintic treatment when compared to nontreated 
controls (Stuedemann et  al., 1989; Larson et  al., 
1995; Stromberg et al., 1997; Loyacano et al., 2002; 
Andresen et al., 2017). Improved conception rates 
that have been previously reported have frequently 
been in conjunction with increases in BW and BCS 
indicating an improvement in the nutritional status 
of the animal. Given the low priority of function 
of reproductive processes such as cyclicity and ini-
tiation of pregnancy (Short and Adams, 1988), it 
is plausible that the improved nutritional status 
often associated with anthelmintic treatment could 
improve reproductive function, especially dur-
ing early lactation when nutritional demands are 
increased. The extended days of parasite protection 
claimed by extended-release eprinomectin allows 
the possibility to improve nutritional status for a 
longer period before reinfection with GIN during 
a critical time when a cow is nursing and trying to 
conceive. When evaluating reproductive success of 
cow herds in the current study (Table 3), there were 
Table 3. Health and reproductive success of cows 
treated with different anthelmintic treatments dur-
ing the grazing season
Item
Treatment1
DOR EPR SEM P-Value3
FEC
 Initial 2.07 2.97 0.49 0.18
 Final 1.76 0.71 0.34 0.02
 Change in −0.30 −2.12 0.60 0.01
Health
 Cow Pinkeye, % 8.4 4.6 --- 0.06
 Live Fly Counts 62 60 11.3 0.62
 Picture Fly Counts 50 58 11.8 0.69
Reproduction, % (no./no.)
 Conception to AI 47 (157/334) 50 (164/327) --- 0.51
 Pregnancy Rate4 88 (729/828) 88 (733/832) --- 0.45
Calving Interval5, days 371 370 2.1 0.72
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, 
Parsippany); EPR = eprinomectin (LongRange; Merial, Duluth, GA).
2Larger SEM presented (n = 828 DOR; n = 832 EPR).
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10.
4Pregnancy rate for 2016.
5Calving interval from 2016 to 2017 calving.
Table 2. Performance of cows treated with different 
anthelmintic treatments during the grazing season
Treatment1
Item DOR EPR SEM P-value3
BW, kg
 Treatment 577 578 11.4 0.85
 Weaning 587 590 10.8 0.40
 Change in4, kg 9 12 4.7 0.13
 Change in4, % 1.95 2.67 0.81 0.12
Performance
 ADG4, kg 0.05 0.08 0.04 0.23
BCS
 Treatment 5.57 5.57 0.07 0.99
 Weaning 5.58 5.60 0.09 0.59
 Change in 0.00 0.02 0.08 0.67
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, 
Parsippany); EPR = eprinomectin (LongRange; Merial, Duluth, GA).
2Larger SEM presented (n = 828 DOR; n = 832 EPR).
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10.
4Calculations based on weight changes from treatment to weaning/
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no differences in conception to AI (DOR = 47%; 
EPR  =  50%; P  =  0.51) or overall breeding sea-
son pregnancy rates (DOR  =  88%; EPR  =  88%; 
P = 0.45). Contrarily, Backes (2016) reported dams 
treated with oral oxfendazole tended to have higher 
overall conception rates when compared to cows 
treated with EPR. However, neither the current 
study nor Backes (2016) reported differences in 
ADG or BW over the course of the grazing sea-
son, indicating nutritional status was not greatly 
improved between the short duration group and 
the extended protection groups in these studies. 
Evaluation of calving distribution in the calving 
season following treatment indicated no differences 
in the number of calves born in the first 21 d as a 
result of treatment (P = 0.98). Analysis of subse-
quent 21-d intervals showed no differences between 
treatment in the number of calves born in each 
interval (P ≥ 0.33). As expected, with no differences 
in calving distribution, there was also no difference 
in calving interval between the 2016 and 2017 calv-
ing season (DOR = 371 d; EPR = 370 d; P = 0.72).
Fecal Egg Counts
Fecal samples were collected from a subset of 
five cooperator herds at the start and end of the 
grazing season for evaluation of FEC as well as 
coproculture if  warranted. Of the five herds sam-
pled, three DOR and four EPR groups warranted 
coprocultures from samples collected at the start 
of the grazing season, which identified the percent 
of each roundworm species found in the fecal sam-
ple. Species identified in DOR groups were pre-
dominantly comprised of Cooperia (100%, 81%, 
and 76%) and Haemonchus (0%, 19%, and 24%). 
Similarly, EPR groups consisted primarily of 
Cooperia (100%, 100%, 82%, and 55%) followed by 
Haemonchus (0%, 0%, 18%, and 12%). Other species 
detected in the EPR group were Oesophagostomum 
(0%, 0%, 0%, and 12%) and 18% of larvae cultured 
were too damaged to identify. No coprocultures 
were warranted for fecal samples taken at the end 
of the grazing season.
Fecal egg count data are reported in Table  3. 
Efficacy is most commonly measured using fecal 
egg reduction tests (FECRT), which compares 
FEC before and after treatment with an anthel-
mintic to measure the reduction in or elimination 
of fecal egg shedding (Taylor et  al., 2002; Coles 
et al., 2006). While initial FEC were not different 
between treatment groups in this study (P = 0.89), 
final FEC were lower (P = 0.02) in EPR cows com-
pared to DOR cows. Subsequently, EPR cows had 
a greater overall reduction in FEC compared to 
DOR cows (P = 0.01). However, FEC of both treat-
ments at both treatment and at final performance 
measurement were far below a threshold that would 
be indicative of clinical parasitism (Bagley et  al., 
1998). We believe that a lack of parasitic infection 
during the grazing season may have resulted in a 
lack of performance differences in this study. Low 
FEC may be a reflection of the types of herds that 
were selected to participate in this study. Because 
of the stringent requirements to qualify for partici-
pation, herds selected were uncommonly well-man-
aged which likely contributed to low overall FEC. 
In similar studies, consisting of treatments that 
included positive control groups and comingled 
treatments, both Pfeifer et  al. (1999) and Ward 
et al. (1991) saw similar FEC during the course of 
the respective trials and reported no performance 
differences following anthelmintic treatment. This 
indicates, in agreeance with previous work, the 
level of parasitic infection in the current study may 
not have been high enough to elicit a production 
response. However, it should be noted that Clark 
et al. (2013) was able to detect significant differences 
in performance between commingled ivermectin 
and extended-release eprinomectin-treated stocker 
calved that had FEC of 5.14 and 0.90, respectively.
Calf Performance
Results for calf growth and performance are 
reported in Table  4. There were no differences in 
birth BW for calves regardless of tier or calving 
season (P = 0.57). Because fall-calving herds were 
treated in the spring while cows were pregnant, birth 
weights of fall calves were analyzed as possible fetal 
programing response to treatment. However, anal-
ysis of birth weights of fall calves indicated no 
difference between treatments (P  =  0.43; data not 
shown). Calf BW at the time of treatment for calves 
in tier two was not different (P = 0.50). Likewise, 
weaning weights were not different between the two 
treatment groups regardless of tier or calving season 
(P  =  0.75), although as expected there was a sea-
son effect (P ≤ 0.01) where fall calves were lighter 
at weaning than spring calves. Subsequently, ADG 
between time of treatment and weaning was not dif-
ferent (P = 0.28), and overall preweaning ADG did 
not differ due to treatment (P = 0.57). While little 
comparable literature exists for evaluation of a short 
duration and extended-release anthelmintic, Backes 
(2016) found increased weaning weight for calves 
from dams treated with oral oxfendazole compared 
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eprinomectin. While milk production has been 
previously implicated in improved performance of 
preweaned calves (Frechette and Lamothe, 1981; 
Ciordia et al., 1982; Stromberg et al., 1997), a lack 
of performance differences in calves makes it an 
unlikely mechanism in the present study. Likewise, 
low FEC found in cows suggest low worm burdens, 
possibly a result of well managed pastures, which 
may have correlated to low levels of parasitic infec-
tion in calves. However, preweaning anthelmintic 
treatment may have implications for improved per-
formance later in both stocker and feedlot phases. 
Stacey et al. (1999) found that preweaning treatment 
with a sustained-release ivermectin bolus improved 
stocker weight gains compared to calves treated 
with a conventional ivermectin pour-on. Clark et al. 
(2015) found that calves entering the feedlot with 
a higher worm burden had reduced growth, com-
promised immunocompetency, and altered carcass 
composition compared to steers with low FEC 
even though both groups were treated upon feed-
lot arrival. Furthermore, Clark et al. (2015) suggest 
that not only do calves with a lesser parasite bur-
den have improved preweaning performance, but 
that early parasite protection may improve lifetime 
production.
Feedlot Performance and Carcass Characteristics
Feedlot performance and carcass measurements 
are presented in Table 5. There was no difference in 
BW between DOR and EPR calves at initiation of 
the feeding period (P = 0.20). Subsequent BW taken 
at reimplantation approximately 50 d after initiation 
of feeding showed a tendency for EPR treated calves 
to weigh more (P = 0.07). While not statistically dif-
ferent (P = 0.13), EPR-treated calves did finish with a 
slight weight advantage compared with DOR calves. 
Although EPR calves finished with slightly heavier 
weights throughout the feeding period, this did not 
correlate into differences in ADG (P ≥ 0.31) between 
treatments. However, when evaluating health of 
calves in the feedlot, EPR calves were treated for var-
ious health issues fewer times compared with DOR 
calves (P = 0.05) indicating improved health status. 
While all essential components of the immune sys-
tem are present at birth, full functionality of immu-
nity is not possibly until 2–4  wk of age and may 
continue to develop through puberty (Wilson et al., 
1996; Chase et al., 2008). Because DOR calves were 
Table  4. Performance and health of calves who 
were treated with different anthelmintic treatments 
during the grazing season
Item
Treatment1
DOR EPR SEM P-Value
BW, kg
 Birth 35 35 0.6 0.57
 Treatment 142 141 7.4 0.50
 Weaning4 231 232 5.5 0.75
Performance, kg
 Treatment ADG5 1.02 1.04 0.04 0.34
 Weaning ADG6 1.05 1.05 0.02 0.66
Health, %
 Pinkeye 18.6 21.1 --- 0.43
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, 
Parsippany); EPR = eprinomectin (LongRange; Merial, Duluth, GA).
2Larger SEM presented (n = 807 DOR; n = 809 EPR).
3P-value: Tendency 0.05 < P ≤ 0.10.
4Actual weaning weight.
5Calculation based on weight change from time of anthelmintic 
treatment to weaning.
6Calculation based on weight change from birth to weaning.
Table  5. Feedlot and carcass characteristics of 




DOR EPR SEM2 P-value3
BW, kg
 Initial 347 354 9.1 0.23
 Reimplant 432 443 7.6 0.08
 Final 545 550 6.8 0.27
Performance, kg
 ADG 1.53 1.53 0.15 0.91
Health
 Treated, % 22.4 13.6 --- 0.06
Carcass Quality
 HCW5, kg 341 343 4.4 0.43
 Dress6, % 61.5 61.8 0.00 0.20
 Backfat, cm. 1.37 1.35 0.05 0.72
 KPH7, % 2.29 2.22 0.05 0.06
 Ribeye area8, cm.2 81.76 82.15 0.94 0.58
 Yield grade9 2.49 2.55 0.08 0.35
 Marbling score10 1083 1097 9.23 0.13
 Quality grade11 12.30 12.52 0.10 0.03
% QG Distribution12
 Avg choice or Higher 40.38 51.43 --- 0.03
 Low choice 47.31 41.43 --- 0.63
 Select and lower 12.31 7.14 --- 0.37
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, 
Parsippany); EPR = eprinomectin (LongRange; Merial, Duluth, GA).
2Larger SEM presented (n = 238 DOR; n = 259 EPR).
3P-value: Significant P ≤ 0.05; Tendency 0.05 < P ≤ 0.10.
4Hot carcass weight.
5Dressing percent.
6Kidney, pelvic, heart fat.
7Marbling score: small: 1,0000, modest: 1,1000, moderate: 1,2000, etc.
8USDA quality grade: 12: Choice-, 13: Choice0, 14: Choice+, etc.
9Percentage of steers in each treatment by quality grade, within 
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protected from parasitic infection for a shorter period 
of the grazing season, as were their dams, exposure 
to parasites may have occurred. Because parasites 
can impair or even inhibit immune response (Gomez-
Munoz et al., 2004), an infection during this critical 
stage of development may have resulted in impaired 
development of the immune system thus impacting 
lifetime immunocompetency. Although FEC in this 
study were low, calves are more susceptible to par-
asites, and although immediate performance was 
not impacted, disruption of immune development 
may have been occurred resulting in higher feedlot 
morbidity.
Subsequent carcass measurements showed no 
differences due to treatment including hot carcass 
weight (HCW), backfat (BF; P ≥ 0.22). Likewise, 
ribeye area (REA) and yield grade (YG) were simi-
lar (P ≥ 0.60) between treatments. Calves treated with 
EPR tended to have a lower kidney, pelvic, and heart 
fat (KPH; P = 0.06). While there was no difference 
(P = 0.13) in marbling score, there was a difference 
in quality grade distribution where EPR calves had a 
greater percentage of carcasses grade average choice 
or higher compared to DOR (38.4% DOR; 49.7% 
EPR; P = 0.03). However, there were no differences 
in the number of carcasses that graded low choice 
or select and lower (P ≥ 0.37). Gardner et al. (1999) 
reported that feedlot morbidity results in a reduc-
tion in quality grade, with a higher percentage of 
steers identified as sick grading Standard. Therefore, 
reduced morbidity and improved quality grade create 
potential for a greater return on initial anthelmintic 
treatment. The results of this study are in agreeance 
with those of Gardner et  al. (1999) where DOR 
calves had a higher incidence of morbidity, resulting 
in an increased health cost, and had a lower average 
quality grade as well as fewer calves grading average 
choice or higher compared with healthier EPR calves.
These results are in line with the previous stud-
ies. Clark et  al. (2013) found that calves treated 
with extended-release eprinomectin did not have 
improved feedlot performance or carcass character-
istics. Likewise, Backes (2016) saw no difference in 
HCW, marbling score, backfat, KPH, YG, or qual-
ity grade distribution between calves treated with 
extended-release eprinomectin or oral oxfendazole 
at weaning. Again, low FEC at initiation of the 
present study may have resulted in a lack of perfor-
mance throughout all phases of production.
Economic Impact, Herd Level
Cow–calf. Performance responses were evaluated 
for differences in economic value between treatment 
groups (Beef Cattle Decision Aids, 2002). Variables 
considered as economically relevant in the cow–
calf  analysis include cow BW, overall breeding 
season pregnancy rates, calving interval, calving 
distribution, and calf  weaning BW. As seen by pro-
duction measurements presented in Tables  1 and 
2, little variation exists between treatment groups. 
Overall breeding season pregnancy rates were not 
different indicating a lack of evidence for increased 
return on investment through increased calf  crop. 
Likewise, calving interval and calving distribution 
were not different, and there were no differences in 
calf  performance.
A lack of  differences in the current study pro-
vides little opportunity for EPR cows to recoup 
the increased cost of  treatment during the pre-
weaning phase. Therefore, the cow–calf  analysis 
sought to determine increased production, in kilo-
grams of  calf  weaned, necessary for the respective 
treatments to be indifferent. Because treating with 
DOR is considered a conventional practice, the 
improved performance needed by EPR calves in 
order to negate the cost difference between treat-
ments was also evaluated.
The partial budget for this analysis is organized 
into two categories—expenses and income associ-
ated with the change. In the present study, this con-
siders a change from DOR to EPR treatment.
Expenses. Because expenses such as forage, feed, 
labor, and reproduction were the same irrespective 
of treatment, only costs associated with differences 
in anthelmintic treatment were considered. Based 
on drug prices at the time of treatment, DOR 
costs $0.32/cc and EPR costs $1.38/cc. The aver-
age amount of medicine administered for cows and 
calves was 12cc and 3cc, respectively, for both the 
treatments. This resulted in a cost of $5.01 per cow–
calf pair treated with DOR and a cost of $21.39 per 
cow–calf pair treated with EPR. Cost difference 
between EPR and DOR treatments was $16.38/pair.
Income. Income was determined by evaluating 
pounds of calf  weaned at the market price on the 
average date of weaning for cooperating herds. 
A market price of $3.40/kg (Iowa auction average 
for Sept. 2016) was used (USDA-AMS, 2016).
Results from the economic analysis are reported 
in Table 6. This analysis indicates that EPR cows 
would need to wean calves with a 4.8  kg weight 
advantage over DOR calves in order to eliminate 
the difference in cost between treatments. For pro-
ducers to recoup the cost of the specific anthel-
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calves would need to add 1.5 and 6.3 kg by weaning, 
respectively. The sensitivity of kilograms of weaned 
calf  required to pay for the cost of anthelmintic 
treatment at alternative calf  prices are reported 
in Table 6. Results of the sensitivity analysis indi-
cate, as expected, that the added weight necessary 
for a producer to recoup the cost of anthelmintic 
treatment was highly variable depending on the 
market price.
While it may not be efficient to retain open 
females in a herd, attention to management and 
marketing of  cull cows can impact profitability. 
Cull cows can represent up to 10–20% of  total 
revenue within the cow–calf  enterprise (Peel and 
Doye, 2008). While marketing is important, man-
agement strategies alone can increase cull cow 
value by 25–45% (Peel and Doye, 2008). Increasing 
pounds of  animal sold can result in increased rev-
enue at comparable prices. Therefore, the use of 
a specific anthelmintic could improve cow–calf  
returns through increased cull cow values. While 
there were no differences in cow BW at weaning, 
evaluation of  BW differences between open cows 
in each treatment group were analyzed for oppor-
tunities for increased cull cow value. Analysis 
shows a slight weight advantage for open DOR 
cows compared to open EPR cows (577 kg DOR; 
571  kg EPR; data not shown) (Table  4). This 
slight weight advantages creates an opportunity 
for producers to realize a greater return, on aver-
age, from cull animals treated with DOR. With an 
average cull cow price of  $1.56/kg from October 
2016 (Sioux Fall, SD) (USDA-AMS, 2016), DOR 
cows had the potential to have an increased 
return of  $9.23/head (Table  6). It is also impor-
tant to note the reduction in incidence of  pinkeye 
in EPR cows. This also provides an opportu-
nity, through reduced health and labor costs, to 
increase returns on the initial cost of  anthelmintic 
treatment. Thus, improved performance in the 
form of  added weight for either weaned calves 
or cull cows and improved herd health have the 
potential to improve return on investment for pre-
weaning anthelmintic treatment for the cow–calf  
enterprise.
While not evident in the current study, perfor-
mance increases necessary to offset cost of  treat-
ment during the preweaning phase may be possible 
in alternative environments such as those with 
higher levels of  parasitic infections. Data eval-
uating the use of  extended-release eprinomectin 
compared to a conventional ivermectin injectable 
in fall-calving beef  herds has shown improve-
ments in conception to AI as well as overall 
breeding season pregnancy rates (Andresen et al., 
2018). Therefore, improvements in reproductive 
efficiency manifested as greater overall season 
pregnancy rates following anthelmintic treatment 
may provide opportunities for a greater return on 
investment.
The same study also found reduced calv-
ing interval and a shift in calving distribution in 
the calving season following initial anthelmintic 
treatment for cows treated with EPR, as well as 
increased weaning weights for their calves. Thus, 
a reduced calving interval and a shift in calving 
distribution following anthelmintic administration 
may improve the probability of  weaning heavier 
calves. Data from Funston et al. (2010) show that 
steers and heifers born in the first 21-day calving 
period perform better than cohorts born in later 
calving periods. Shifting calving distribution may 
also improve cow pregnancy rates by increasing 
the postpartum recovery time. This may result in a 
larger calf  crop as well as increased pounds of  calf  
weaned per cow. These data indicate alternative 
conditions to the ones in the current study have 
the potential to generate a greater return on invest-
ment following treatment with EPR. However, it 
is important to note that improvements in returns 
based on improved performance will be highly 
dependent on the economic conditions at the time 
calves are marketed.
Table 6. Economic analysis and breakeven weight 
for calves and cull cows treated with different 
anthelmintic treatments during preweaning
Treatment1
DOR EPR Difference2
Herd size3 100 100 ---
Cost of Treatment $5.01 $21.39 $16.38
Average WW, kg 238 238 ---
Breakeven weight needed4, kg
 $2.73/kg 1.8 7.9 6.0
 $3.40/kg5 1.5 6.3 4.8
 $4.06/kg 1.2 5.3 4.0
Average cull cow weight, kg. 577 571 6
Cull cow value6, $/hd $902.41 $893.78 $9.23
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, 
Parsippany); EPR = eprinomectin (LongRange; Merial, Duluth, GA).
2Cost difference that must be made up by EPR calves in order to 
breakeven with a conventional treatment.
3Budget utilized from Beef Cattle Decision Aids (2002).
4Added weaning weight necessary above the average for treatments 
to breakeven at various market prices.
5Weighted average market price of medium to large, frame 1, 227–
249 kg fed calves for Iowa auctions on September 2016.
6Value calculated based on October 2016 Boning cow 544–907 kg 
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It is also important to note that estimates from 
this analysis are likely conservative. The compari-
son in the current study was made between extend-
ed-release eprinomectin and a single treatment of 
a short duration anthelmintic. Because the goal of 
this study was not to compare the effectiveness of 
deworming, no comparison was made using a short 
duration anthelmintic multiple times throughout 
the grazing season to create an equal number of 
protected days as EPR, which would have increased 
initial treatment costs for DOR. The goal of the 
current study was to evaluate extended-release 
eprinomectin compared to conventional deworm-
ers in common production settings where deworm-
ing typically occurs once during the grazing season 
which was also the basis of the economic analysis 
conducted.
Feedlot. The enterprise budget for this analysis 
used actual income and expense records for each 
treatment group and prices reported by TCSCF.
Expense. Costs including feed, interest, death 
loss, and yardage were assumed equal between 
treatment groups as these costs were accrued 
regardless of  anthelmintic treatment. Because 
there were no differences in weaning weight, place-
ment cost at the time of  delivery was the same for 
each group ($2.60/kg) based off  reported market 
price at the time of  delivery by TCSCF. Records 
obtained through TCSCF allowed for individual 
animal health records including how many times a 
calf  was treated and the cost of  health treatments 
throughout the feeding period. Calves treated 
with DOR preweaning had a greater number of 
health issues (Table  5) throughout the feedlot 
phase resulting in higher health costs of  $6.00 per 
animal.
Income. Fed cattle prices used were the average 
price received by producers in this study as reported 
by TCSCF. Average final BW was used to deter-
mine the live value of animals within each treat-
ment group. This price accounted for premiums 
and discounts that were paid for various quality, 
yield, and weight characteristics. Although quality 
grade distribution presented in Table 5 indicates a 
larger number of carcasses grading average choice 
or greater for EPR-treated calves, premiums for 
YG, CAB, and prime were consistent between the 
two treatment groups. This may have been a result 
of variability in marketing time as market dates for 
finished cattle ranged from 21 March 2017 to 18 
July 2017. While fed cattle price was not different 
between treatment groups ($2.87/kg), EPR calves 
did finish the feedlot phase with a slight weight 
advantage over DOR calves (550 kg DOR; 557 kg 
EPR) resulting in a slight increase in income on a 
live weight basis.
Results of the feedlot budget analysis are 
reported in Table 7. The culminating effect of both 
healthier and heavier EPR calves resulted in a lower 
breakeven price ($1.10 DOR vs. $1.08 EPR) and 
an opportunity for slightly higher profits ($200.11 
DOR; $227.22 EPR) per animal.
Retained Ownership
As seen by slightly higher returns for EPR calves 
in the feedlot, administering EPR preweaning may 
be able to make up the cost difference between the 
two anthelmintic treatments.
For producers operating on a retained owner-
ship platform, like cooperating herds in this study, 
opportunities to capitalize on a higher calfhood 
deworming investment are much greater. While 
a lack of  differences in the cow–calf  portion of 
this study indicated little potential for improved 
returns for cow–calf  production alone, improved 
immunocompetency and higher final BW of  EPR 
calves may allow producers to realize a return 
on investment of  the original treatment given 
preweaning.
While, on average, participating cooperator 
herds anecdotally noted returns on the added cost 
of extended-release eprinomectin, variability in 
market conditions over time will greatly impact 
economic outcomes for environments outside of 
the current study. Returns realized by implement-
ing a value-added practice will be highly impacted 
Table  7. Economic analysis and breakeven prices 
for feedlot animals treated with different anthel-
mintic treatments preweaning
Treatment1
$/steer2 DOR EPR Difference2
Total costs $1,375.49 $1,369.18 $6.31
Income $1,576 $1,596 $21
Profit $200.11 $227.19 $27.08
Breakeven selling price, ($/kg)
 For variable costs $2.43 $2.38 $0.05
 For all costs $2.49 $2.45 $0.04
1Treatment: DOR = doramectin (Dectomax; Zoetis Animal Health, 
Parsippany); EPR = eprinomectin (LongRange; Merial, Duluth, GA).
2Budget utilized from Iowa State University Extension and Outreach 
(Ag Decision Maker, B1-21). All market prices were average of actual 
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by differences in cattle prices at key marketing times 
including weaning, backgrounding, or finishing. 
While retained ownership may increase price risk 
due to delayed marketing and potentially added 
price volatility, cow–calf  producers have oppor-
tunities to mitigate some production risk through 
value added practices such as preventative health 
protocols that reduce performance variability 
(White et al., 2007).
CONCLUSION
To our knowledge, this is one of  the two stud-
ies published to date that evaluates the effect of 
extended-release eprinomectin on cow–calf  pro-
duction and feedlot performance of  progeny 
compared to a conventional, short duration anthel-
mintic. The results of  this study show no differ-
ence in cow performance or reproductive success 
over the course of  the grazing season. Likewise, 
there were no improvements in calf  preweaning 
performance or feedlot performance. While car-
cass characteristics were largely unchanged due 
to treatment, there was an improvement in quality 
grade for EPR-treated calves. Improved immuno-
competency via extended parasite protection dur-
ing the preweaning phase may have had long-term 
impacts on feedlot morbidity resulting in improved 
quality grade measurements. This was evident by a 
lower percent of  illness during the feeding phase, 
increased marbling score, a higher average quality 
grade, and a higher percent of  EPR calves grading 
average choice or higher, presenting a chance to 
increased returns to producers by have more ani-
mals qualify for value-added programs.
It is important to note that FEC counts were 
very low in this study and may have provided very 
little opportunity for performance improvement 
following anthelmintic treatment in both treatment 
groups. Thus, more research is needed in popula-
tions carrying greater parasitic burdens to evalu-
ate the effect of extended-release eprinomectin on 
cow–calf  production.
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